Back to Studies

P1026S / PK in Pregnancy

Pharmacokinetic Properties of Antiretroviral and Related Drugs During Pregnancy and
Postpartum

Study Status

Closed to Follow Up

DAIDS Number

10040

IND Number

64,535

Clinical Trials Link

Study Chair

Study Vice-Chair

DAIDS Medical Officer

Clinical Research Manager

Field Representative

Laboratory Data Manager (LDM)

Laboratory Specialist

Laboratory Technologist

Pediatrician

Proposal Statistician

Senior Statistician

Virologist

Manuscripts

Abstracts

Effect of Pregnancy on Pharmacokinetics of Boosted Indinavir

Conference

13th International Workshop on Clinical Pharmacology of HIV Therapy

Study

P1026S

Adequate lopinavir exposure achieved with a higher dose during the 3rd trimester of pregnancy.

Conference

13th Conference on Retroviruses and Opportunistic Infections

Study

P1026S

Authors

Mark Mirochnick, Alice M. Stek, Edmund Capparelli, Brookie M. Best, Diane Holland, James D. Connor, ChengCheng Hu, Elizabeth (Betsy) Smith, Jennifer S. Read

Pharmacokinetics of Tenofovir Alafenamide 25 mg with PK Boosters During Pregnancy and Postpartum

Conference

20th International Workshop on Clinical Pharmacology of HIV< Hepatitis & Other Antiviral Drugs Conference

Study

P1026S

Authors

K Brooks, M Pinilla, J Wang, D Shapiro, E Capparelli, E Smith, N Chakhtoura, A Stek, M Mirochnick, B Best for the IMPAACT 1026s Protocol team

Pharmacokinetics of darunavir boosted with cobicistat during pregnancy and postpartum

Conference

IAS 2018

Study

P1026S

Authors

J Momper, B Best, J Wang, A Stek, DE Shapiro, K George, E Barr, K Rungruengthanakit, E Smith, N Chakhtoura, EV Capparelli, M Mirochnick

Pharmacokinetics of increased dose darunavir during late pregnancy and postpartum

Conference

CROI 2016

Study

P1026S

Authors

Alice Stek, Brookie Best, Edmund Caparrelli, JiaJia Wang, David Shapiro, Tim Cressey, Elizabeth Smith, Regis Kreitchman, Nahida Chakhtoura, Mark Mirochnick for the IMPAACT P1026s team